Definition and prevalence
Fatigue in palliative care is commonly described as a subjective feeling of extreme tiredness, weakness, or energy depletion, which is disproportionate to recent activity and unrelieved by rest. [1,2] It arises from multiple sources, including physical issues like anaemia or infection, and psychological factors such as emotional distress and depression, making it highly variable between patients depending on their health status and disease progression. [3] This complexity makes fatigue difficult to fully manage in palliative care settings.
Fatigue is particularly prevalent in patients with advanced cancer or undergoing chemotherapy, affecting up to 80% of these individuals, with nearly 99% of those receiving chemotherapy reporting it as a persistent issue. [1] Cancer-related fatigue is often more severe than in non-cancer populations, worsened by treatment and often persisting through end-of-life care. [3,4]
In non-cancer conditions, such as end-stage renal disease, fatigue is similarly common due to muscle atrophy, anaemia, and metabolic imbalances from long-term dialysis. [2] This leads to reduced physical and mental well-being, further complicating daily activities and quality of life. [2] Fatigue in palliative care, regardless of the underlying cause, presents unique challenges due to its subjective nature and the interplay of disease progression and treatments. [3]
Assessment
Assessing fatigue in palliative care requires both physical and psychological evaluations. Common tools include the Brief Fatigue Inventory (BFI) and Piper Fatigue Scale (PFS), which provide numerical ratings for fatigue severity and its impact on daily functioning, guiding clinical decisions. [1,3] The Edmonton Symptom Assessment System (ESAS) is also frequently used in cancer-related fatigue, offering a quick, patient-reported scale (0–10) that assesses fatigue alongside other key symptoms such as pain and anxiety. [1,3]
Patient-reported outcomes, such as fatigue diaries, add depth to assessments by tracking daily energy variations and activity levels, providing valuable longitudinal data for more tailored management. [1] Simple screening questions, like ‘Do you feel unusually tired or weak?’, are also practical in triggering more comprehensive assessments, especially when integrated into routine care. [3] This approach creates a thorough, yet patient-centred, understanding of fatigue in advanced illness.
Non-pharmacological treatment
Managing fatigue in palliative care often requires a multidimensional approach, with non-pharmacological interventions forming a core part of the strategy. Allied health professionals play a key role in managing fatigue in palliative care populations. Exercise-based interventions, though adapted to the abilities of patients with terminal illness, have demonstrated benefits in reducing fatigue and maintaining mobility. [2,5] Light physical activity, such as walking, cycling, or resistance training, helps address the physical aspects of fatigue by counteracting the deconditioning associated with prolonged illness. [2] These interventions may also have psychological benefits, as they allow patients to engage in meaningful activities, fostering a sense of control over their condition and helping to maintain emotional well-being. [3,5]
Mindfulness-based interventions, such as mindfulness meditation, yoga, and art therapy, have shown promise in managing both the physical and psychological dimensions of fatigue, particularly in patients who may not be able to engage in more strenuous physical activity. [3,4] These practices help reduce emotional stress and foster present-moment awareness, addressing the cognitive and emotional burdens that often accompany fatigue in terminal illness. [4] The use of mindfulness can provide a way for patients to cope with the mental strain of their illness, improving their capacity to manage the overall impact of fatigue. [3] In addition to mindfulness-based practices, integrative approaches like lifestyle modifications and complementary therapies—including nutrition counselling, acupuncture, and gentle physical activity—are increasingly recognised for their role in alleviating fatigue. [6] These strategies offer holistic support, aiming to enhance physical vitality and emotional resilience, which can be particularly valuable for palliative care populations facing complex symptoms. [6]
Energy conservation strategies and psychosocial support also play a vital role in fatigue management. Techniques such as pacing, prioritising activities, and incorporating regular rest periods help patients use their energy more efficiently, thereby mitigating the effects of fatigue on daily life. [1,3] Fatigue diaries are a useful tool for tracking energy levels and fluctuations throughout the day, allowing patients to make more informed decisions about how to allocate their energy. [1] Cognitive Behavioural Therapy (CBT) has been particularly useful in reframing negative thoughts about fatigue, promoting more adaptive coping strategies, and improving emotional resilience, especially in cases of cancer-related fatigue. [3]
Pharmacological treatment
In managing fatigue within palliative care, pharmacological interventions often focus on psychostimulants and corticosteroids, with other agents such as melatonin and testosterone considered in specific cases. Psychostimulants, such as methylphenidate and modafinil, are commonly used to alleviate cancer-related fatigue. Methylphenidate has shown some effectiveness in improving fatigue scores, such as the Brief Fatigue Inventory (BFI), although patient responses vary. Some patients experience notable relief, while others report minimal improvement, with evidence remaining mixed due to small trial sizes and potential placebo effects. [1,7] Despite this variability, psychostimulants are often regarded as a useful short-term option for managing fatigue, provided careful monitoring is in place. [1]
Corticosteroids, such as dexamethasone and methylprednisolone, are also widely used in palliative care, especially when fatigue is linked to inflammation or cachexia. These medications may offer temporary relief by enhancing energy levels and appetite, but long-term use is discouraged due to potential side effects such as myopathy and immunosuppression. [1] Short courses of corticosteroids are typically prescribed to provide symptom control while minimising the risk of adverse effects. [7]
Other pharmacological agents, such as melatonin and testosterone, are less frequently used but may be considered in specific cases. Melatonin has been explored for its anti-inflammatory and antioxidative properties. [7] Testosterone therapy may be appropriate for patients with documented hypogonadism or muscle wasting, although the evidence supporting its effectiveness in addressing fatigue is inconsistent. [7] Ultimately, the choice of pharmacological treatment should be tailored to the patient’s individual condition, with a careful balance between potential benefits and side effects.